Objective:

To identify methodological concerns affecting causal interpretation of a multicenter study comparing left ventricular unloading with VA-ECMO alone in cardiogenic shock.

Approach:

• Eligibility and time zero: The letter questions whether requiring at least 48 hours of VA-ECMO is compatible with defining eligibility and follow-up from cannulation, since the duration is only known afterward.
• Treatment assignment: Unloading was classified by receipt within 24 hours after cannulation, although follow-up began at cannulation. The authors note that this may create a grace-period problem and suggest methods such as cloning, artificial censoring, and inverse-probability-of-c…
• Time-varying confounding: Unloading decisions were prompted by evolving clinical findings that may predict outcomes and be affected by ECMO flow or inotropic therapy; baseline propensity-score weighting may not address this.
• Center and device differences: IABP use was concentrated in Paris and Impella use in Hamburg, where practices and patient characteristics differed, limiting separation of device, center, and treatment-policy effects.

Key Findings:

• The reported weighted risk difference in 60-day mortality was 1.4% (95% CI, −11.8% to 14.6%).
• The letter states that this estimate rules out neither clinically meaningful benefit nor harm.
• The authors characterize the result as no detectable association in the weighted overlap population receiving local treatment practices, rather than evidence of equivalence.

Interpretation:

The letter argues that causal interpretation is constrained by possible post-baseline eligibility selection, the 24-hour exposure grace period, time-varying confounding, and near-deterministic coupling of device and center.

Limitations:

• The context does not provide the original study’s full methods or results beyond the details cited in the letter.
• Aortic velocity-time integral data were unavailable from one center, and unloading triggers were not standardized.

Conclusion:

The letter calls for clarification of the 48-hour eligibility criterion and reanalysis of the 24-hour grace period. It also proposes emulating clinically defined dynamic strategies using time-updated hemodynamic and echocardiographic measurements.

Sources:

• Article context supplied by the user; no source URL provided